Medical Care

Global GMP Peptides Market Research Report 2025

The global market for GMP Peptides was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Good Manufacturing Practice (GMP) peptides are peptides that are manufactured and produced in compliance with strict quality and safety standards, ensuring their suitability for pharmaceutical, clinical, and biotechnological applications.
The GMP peptides market is currently experiencing rapid growth, with its size expanding gradually and sales steadily increasing. GMP peptides find widespread application in specific uses within the pharmaceutical and biotechnology sectors, particularly excelling in the treatment of chronic diseases and cancer. Their unique biological activity and efficient pharmacological properties position them as a focal point in the development of next-generation drugs. In the future, GMP peptides are poised to continue their advancement in the field of innovative pharmaceuticals, not only extending their applications in the treatment of existing diseases but also potentially venturing into new therapeutic areas, driving continuous innovation throughout the market.
This report aims to provide a comprehensive presentation of the global market for GMP Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Peptides.
The GMP Peptides market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GMP Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GMP Peptides companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Bio Basic
Genscript
ScinoPharm
CBL Patras
Piramal Pharma Solutions
CPC Scientific
AnaSpec
CEM Corporation
ANYGEN
CSBio
Segment by Type
Custom Peptides
Long Peptides
Other
Segment by Application
Pharmaceuticals
Research
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Peptides company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GMP Peptides Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Custom Peptides
1.2.3 Long Peptides
1.2.4 Other
1.3 Market by Application
1.3.1 Global GMP Peptides Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global GMP Peptides Market Perspective (2020-2031)
2.2 Global GMP Peptides Growth Trends by Region
2.2.1 Global GMP Peptides Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 GMP Peptides Historic Market Size by Region (2020-2025)
2.2.3 GMP Peptides Forecasted Market Size by Region (2026-2031)
2.3 GMP Peptides Market Dynamics
2.3.1 GMP Peptides Industry Trends
2.3.2 GMP Peptides Market Drivers
2.3.3 GMP Peptides Market Challenges
2.3.4 GMP Peptides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GMP Peptides Players by Revenue
3.1.1 Global Top GMP Peptides Players by Revenue (2020-2025)
3.1.2 Global GMP Peptides Revenue Market Share by Players (2020-2025)
3.2 Global GMP Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by GMP Peptides Revenue
3.4 Global GMP Peptides Market Concentration Ratio
3.4.1 Global GMP Peptides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GMP Peptides Revenue in 2024
3.5 Global Key Players of GMP Peptides Head office and Area Served
3.6 Global Key Players of GMP Peptides, Product and Application
3.7 Global Key Players of GMP Peptides, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 GMP Peptides Breakdown Data by Type
4.1 Global GMP Peptides Historic Market Size by Type (2020-2025)
4.2 Global GMP Peptides Forecasted Market Size by Type (2026-2031)
5 GMP Peptides Breakdown Data by Application
5.1 Global GMP Peptides Historic Market Size by Application (2020-2025)
5.2 Global GMP Peptides Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America GMP Peptides Market Size (2020-2031)
6.2 North America GMP Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America GMP Peptides Market Size by Country (2020-2025)
6.4 North America GMP Peptides Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GMP Peptides Market Size (2020-2031)
7.2 Europe GMP Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe GMP Peptides Market Size by Country (2020-2025)
7.4 Europe GMP Peptides Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GMP Peptides Market Size (2020-2031)
8.2 Asia-Pacific GMP Peptides Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific GMP Peptides Market Size by Region (2020-2025)
8.4 Asia-Pacific GMP Peptides Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GMP Peptides Market Size (2020-2031)
9.2 Latin America GMP Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America GMP Peptides Market Size by Country (2020-2025)
9.4 Latin America GMP Peptides Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GMP Peptides Market Size (2020-2031)
10.2 Middle East & Africa GMP Peptides Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa GMP Peptides Market Size by Country (2020-2025)
10.4 Middle East & Africa GMP Peptides Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem GMP Peptides Introduction
11.1.4 Bachem Revenue in GMP Peptides Business (2020-2025)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Details
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide GMP Peptides Introduction
11.2.4 PolyPeptide Revenue in GMP Peptides Business (2020-2025)
11.2.5 PolyPeptide Recent Development
11.3 CordenPharma
11.3.1 CordenPharma Company Details
11.3.2 CordenPharma Business Overview
11.3.3 CordenPharma GMP Peptides Introduction
11.3.4 CordenPharma Revenue in GMP Peptides Business (2020-2025)
11.3.5 CordenPharma Recent Development
11.4 AmbioPharm
11.4.1 AmbioPharm Company Details
11.4.2 AmbioPharm Business Overview
11.4.3 AmbioPharm GMP Peptides Introduction
11.4.4 AmbioPharm Revenue in GMP Peptides Business (2020-2025)
11.4.5 AmbioPharm Recent Development
11.5 USV Peptides
11.5.1 USV Peptides Company Details
11.5.2 USV Peptides Business Overview
11.5.3 USV Peptides GMP Peptides Introduction
11.5.4 USV Peptides Revenue in GMP Peptides Business (2020-2025)
11.5.5 USV Peptides Recent Development
11.6 Bio Basic
11.6.1 Bio Basic Company Details
11.6.2 Bio Basic Business Overview
11.6.3 Bio Basic GMP Peptides Introduction
11.6.4 Bio Basic Revenue in GMP Peptides Business (2020-2025)
11.6.5 Bio Basic Recent Development
11.7 Genscript
11.7.1 Genscript Company Details
11.7.2 Genscript Business Overview
11.7.3 Genscript GMP Peptides Introduction
11.7.4 Genscript Revenue in GMP Peptides Business (2020-2025)
11.7.5 Genscript Recent Development
11.8 ScinoPharm
11.8.1 ScinoPharm Company Details
11.8.2 ScinoPharm Business Overview
11.8.3 ScinoPharm GMP Peptides Introduction
11.8.4 ScinoPharm Revenue in GMP Peptides Business (2020-2025)
11.8.5 ScinoPharm Recent Development
11.9 CBL Patras
11.9.1 CBL Patras Company Details
11.9.2 CBL Patras Business Overview
11.9.3 CBL Patras GMP Peptides Introduction
11.9.4 CBL Patras Revenue in GMP Peptides Business (2020-2025)
11.9.5 CBL Patras Recent Development
11.10 Piramal Pharma Solutions
11.10.1 Piramal Pharma Solutions Company Details
11.10.2 Piramal Pharma Solutions Business Overview
11.10.3 Piramal Pharma Solutions GMP Peptides Introduction
11.10.4 Piramal Pharma Solutions Revenue in GMP Peptides Business (2020-2025)
11.10.5 Piramal Pharma Solutions Recent Development
11.11 CPC Scientific
11.11.1 CPC Scientific Company Details
11.11.2 CPC Scientific Business Overview
11.11.3 CPC Scientific GMP Peptides Introduction
11.11.4 CPC Scientific Revenue in GMP Peptides Business (2020-2025)
11.11.5 CPC Scientific Recent Development
11.12 AnaSpec
11.12.1 AnaSpec Company Details
11.12.2 AnaSpec Business Overview
11.12.3 AnaSpec GMP Peptides Introduction
11.12.4 AnaSpec Revenue in GMP Peptides Business (2020-2025)
11.12.5 AnaSpec Recent Development
11.13 CEM Corporation
11.13.1 CEM Corporation Company Details
11.13.2 CEM Corporation Business Overview
11.13.3 CEM Corporation GMP Peptides Introduction
11.13.4 CEM Corporation Revenue in GMP Peptides Business (2020-2025)
11.13.5 CEM Corporation Recent Development
11.14 ANYGEN
11.14.1 ANYGEN Company Details
11.14.2 ANYGEN Business Overview
11.14.3 ANYGEN GMP Peptides Introduction
11.14.4 ANYGEN Revenue in GMP Peptides Business (2020-2025)
11.14.5 ANYGEN Recent Development
11.15 CSBio
11.15.1 CSBio Company Details
11.15.2 CSBio Business Overview
11.15.3 CSBio GMP Peptides Introduction
11.15.4 CSBio Revenue in GMP Peptides Business (2020-2025)
11.15.5 CSBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global GMP Peptides Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Custom Peptides
Table 3. Key Players of Long Peptides
Table 4. Key Players of Other
Table 5. Global GMP Peptides Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global GMP Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global GMP Peptides Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global GMP Peptides Market Share by Region (2020-2025)
Table 9. Global GMP Peptides Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global GMP Peptides Market Share by Region (2026-2031)
Table 11. GMP Peptides Market Trends
Table 12. GMP Peptides Market Drivers
Table 13. GMP Peptides Market Challenges
Table 14. GMP Peptides Market Restraints
Table 15. Global GMP Peptides Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global GMP Peptides Market Share by Players (2020-2025)
Table 17. Global Top GMP Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GMP Peptides as of 2024)
Table 18. Ranking of Global Top GMP Peptides Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by GMP Peptides Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of GMP Peptides, Headquarters and Area Served
Table 21. Global Key Players of GMP Peptides, Product and Application
Table 22. Global Key Players of GMP Peptides, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global GMP Peptides Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global GMP Peptides Revenue Market Share by Type (2020-2025)
Table 26. Global GMP Peptides Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global GMP Peptides Revenue Market Share by Type (2026-2031)
Table 28. Global GMP Peptides Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global GMP Peptides Revenue Market Share by Application (2020-2025)
Table 30. Global GMP Peptides Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global GMP Peptides Revenue Market Share by Application (2026-2031)
Table 32. North America GMP Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America GMP Peptides Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America GMP Peptides Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe GMP Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe GMP Peptides Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe GMP Peptides Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific GMP Peptides Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific GMP Peptides Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific GMP Peptides Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America GMP Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America GMP Peptides Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America GMP Peptides Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa GMP Peptides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa GMP Peptides Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa GMP Peptides Market Size by Country (2026-2031) & (US$ Million)
Table 47. Bachem Company Details
Table 48. Bachem Business Overview
Table 49. Bachem GMP Peptides Product
Table 50. Bachem Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 51. Bachem Recent Development
Table 52. PolyPeptide Company Details
Table 53. PolyPeptide Business Overview
Table 54. PolyPeptide GMP Peptides Product
Table 55. PolyPeptide Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 56. PolyPeptide Recent Development
Table 57. CordenPharma Company Details
Table 58. CordenPharma Business Overview
Table 59. CordenPharma GMP Peptides Product
Table 60. CordenPharma Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 61. CordenPharma Recent Development
Table 62. AmbioPharm Company Details
Table 63. AmbioPharm Business Overview
Table 64. AmbioPharm GMP Peptides Product
Table 65. AmbioPharm Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 66. AmbioPharm Recent Development
Table 67. USV Peptides Company Details
Table 68. USV Peptides Business Overview
Table 69. USV Peptides GMP Peptides Product
Table 70. USV Peptides Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 71. USV Peptides Recent Development
Table 72. Bio Basic Company Details
Table 73. Bio Basic Business Overview
Table 74. Bio Basic GMP Peptides Product
Table 75. Bio Basic Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 76. Bio Basic Recent Development
Table 77. Genscript Company Details
Table 78. Genscript Business Overview
Table 79. Genscript GMP Peptides Product
Table 80. Genscript Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 81. Genscript Recent Development
Table 82. ScinoPharm Company Details
Table 83. ScinoPharm Business Overview
Table 84. ScinoPharm GMP Peptides Product
Table 85. ScinoPharm Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 86. ScinoPharm Recent Development
Table 87. CBL Patras Company Details
Table 88. CBL Patras Business Overview
Table 89. CBL Patras GMP Peptides Product
Table 90. CBL Patras Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 91. CBL Patras Recent Development
Table 92. Piramal Pharma Solutions Company Details
Table 93. Piramal Pharma Solutions Business Overview
Table 94. Piramal Pharma Solutions GMP Peptides Product
Table 95. Piramal Pharma Solutions Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 96. Piramal Pharma Solutions Recent Development
Table 97. CPC Scientific Company Details
Table 98. CPC Scientific Business Overview
Table 99. CPC Scientific GMP Peptides Product
Table 100. CPC Scientific Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 101. CPC Scientific Recent Development
Table 102. AnaSpec Company Details
Table 103. AnaSpec Business Overview
Table 104. AnaSpec GMP Peptides Product
Table 105. AnaSpec Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 106. AnaSpec Recent Development
Table 107. CEM Corporation Company Details
Table 108. CEM Corporation Business Overview
Table 109. CEM Corporation GMP Peptides Product
Table 110. CEM Corporation Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 111. CEM Corporation Recent Development
Table 112. ANYGEN Company Details
Table 113. ANYGEN Business Overview
Table 114. ANYGEN GMP Peptides Product
Table 115. ANYGEN Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 116. ANYGEN Recent Development
Table 117. CSBio Company Details
Table 118. CSBio Business Overview
Table 119. CSBio GMP Peptides Product
Table 120. CSBio Revenue in GMP Peptides Business (2020-2025) & (US$ Million)
Table 121. CSBio Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report


List of Figures
Figure 1. GMP Peptides Picture
Figure 2. Global GMP Peptides Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global GMP Peptides Market Share by Type: 2024 VS 2031
Figure 4. Custom Peptides Features
Figure 5. Long Peptides Features
Figure 6. Other Features
Figure 7. Global GMP Peptides Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global GMP Peptides Market Share by Application: 2024 VS 2031
Figure 9. Pharmaceuticals Case Studies
Figure 10. Research Case Studies
Figure 11. Other Case Studies
Figure 12. GMP Peptides Report Years Considered
Figure 13. Global GMP Peptides Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global GMP Peptides Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global GMP Peptides Market Share by Region: 2024 VS 2031
Figure 16. Global GMP Peptides Market Share by Players in 2024
Figure 17. Global Top GMP Peptides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GMP Peptides as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by GMP Peptides Revenue in 2024
Figure 19. North America GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America GMP Peptides Market Share by Country (2020-2031)
Figure 21. United States GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe GMP Peptides Market Share by Country (2020-2031)
Figure 25. Germany GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific GMP Peptides Market Share by Region (2020-2031)
Figure 33. China GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America GMP Peptides Market Share by Country (2020-2031)
Figure 41. Mexico GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa GMP Peptides Market Share by Country (2020-2031)
Figure 45. Turkey GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE GMP Peptides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Bachem Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 49. PolyPeptide Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 50. CordenPharma Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 51. AmbioPharm Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 52. USV Peptides Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 53. Bio Basic Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 54. Genscript Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 55. ScinoPharm Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 56. CBL Patras Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 57. Piramal Pharma Solutions Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 58. CPC Scientific Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 59. AnaSpec Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 60. CEM Corporation Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 61. ANYGEN Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 62. CSBio Revenue Growth Rate in GMP Peptides Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies